MNZO.US Manzo Pharmaceut

Financial Services Capital Markets USA Stocks
0.0002 USD
Close of Nov 14, 2026
Market cap
USD 1.00M
P/E
-
P/B
-
ROE
-8.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2016.

Is MNZO.US undervalued?

Graham number

The Graham number of Manzo Pharmaceut cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Manzo Pharmaceut fundamental analysis

No fundamental analysis for Manzo Pharmaceut yet.

Manzo Pharmaceut stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Manzo Pharmaceut

ExxSun Corporation focuses on clean energy infrastructure investment and residential and commercial real estate development, integrating localized renewable energy systems. The company is involved in developing an integrated Energy-as-a-Service (EaaS) platform, combining solar roofs, solar flowers, wind turbines, and 50 kW battery storage solutions into localized microgrids; and providing solar roof installation services alongside the development of high-demand, energy-effic…

Full company profile